Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Clin Cancer Res. 2016 Sep 15;23(1):73–80. doi: 10.1158/1078-0432.CCR-15-3169

Fig. 4. Receipt of hERG blockers correlate with a better GBM patient survival.

Fig. 4

Patients who received more than one hERG blocker were compared to patients that had not received any hERG blockers and there was a statistically significant difference in their survival (p=0.0015).